Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging

The authors of this study have shown that, with future study to prove their safety, iron chelates may have the potential to eliminate one of the greatest concerns of gadolinium-based contrast agents: the possible long-term toxicity.